SGMT Sagimet Biosciences Inc.
Nasdaq · SEC CIK 1400118 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $4.91M 10 sales by 5 insiders
- Filings on record
- 80 since 2023-07-20, latest 2026-08-17 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Kemble George | Executive COB, Dir | — | $4.22M |
| Happel David | Pres, CEO, Dir | — | $561.9K |
| Rozek Elizabeth | Chief Legal, Admin. Off | — | $95.9K |
| Martins Eduardo Bruno | Chief Medical Off | — | $19.5K |
| Chauche Thierry | CFO | — | $7,032 |
Transactions 59
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-17 16:05 | 2026-08-14 | SGMT | Kemble George | Dir | M - OptEx | $6.36 | +351.0K | 413.1K | +565% | +$2.23M |
| DT | 2026-08-17 16:05 | 2026-08-14 | SGMT | Kemble George | Dir | S - Sale+OE | $10.23 | -351.0K | 62.2K | -85% | -$3.59M |
| DMT | 2026-08-12 19:41 | 2026-08-11 | SGMT | Kemble George | Dir | M - OptEx | $6.36 | +20.2K | 82.4K | +33% | +$128.5K |
| DT | 2026-08-12 19:41 | 2026-08-11 | SGMT | Kemble George | Dir | S - Sale+OE | $9.95 | -20.2K | 62.2K | -25% | -$201.1K |
| 2026-07-22 16:05 | 2026-07-20 | SGMT | Happel David | Pres, CEO, Dir | S - Sale | $7.76 | -64.1K | 741.6K | -8% | -$497.1K | |
| 2026-07-22 16:05 | 2026-07-20 | SGMT | Rozek Elizabeth | Chief Legal, Admin. Off | S - Sale | $7.76 | -10.5K | 224.4K | -4% | -$81.8K | |
| T | 2026-07-22 16:05 | 2026-07-20 | SGMT | Kemble George | Dir | S - Sale | $7.46 | -18.8K | 62.2K | -23% | -$140.5K |
| D | 2026-02-20 | 2026-02-19 | SGMT | Martins Eduardo Bruno | Chief Medical Off | A - Grant | $0.00 | +44.0K | 147.3K | +43% | $0 |
| D | 2026-02-20 | 2026-02-19 | SGMT | Happel David | Pres, CEO, Dir | A - Grant | $0.00 | +128.0K | 805.6K | +19% | $0 |
| D | 2026-02-20 | 2026-02-19 | SGMT | Rozek Elizabeth | Chief Legal, Admin. Off | A - Grant | $0.00 | +44.0K | 235.0K | +23% | $0 |
| D | 2026-02-20 | 2026-02-19 | SGMT | Chauche Thierry | CFO | A - Grant | $0.00 | +44.0K | 59.7K | +280% | $0 |
| 2026-02-12 | 2026-02-10 | SGMT | Martins Eduardo Bruno | Chief Medical Off | S - Sale | $5.36 | -3,640 | 103.3K | -3% | -$19.5K | |
| 2026-02-12 | 2026-02-10 | SGMT | Happel David | Pres, CEO, Dir | S - Sale | $5.36 | -12.1K | 677.6K | -2% | -$64.9K | |
| 2026-02-12 | 2026-02-10 | SGMT | Rozek Elizabeth | Chief Legal, Admin. Off | S - Sale | $5.36 | -2,622 | 191.0K | -1% | -$14.1K | |
| 2026-02-12 | 2026-02-10 | SGMT | Chauche Thierry | CFO | S - Sale | $5.36 | -1,312 | 15.7K | -8% | -$7,032 | |
| 2025-11-21 | 2025-11-20 | SGMT | Kemble George | Executive COB, Dir | S - Sale | $7.69 | -37.7K | 81.0K | -32% | -$289.8K | |
| D | 2025-11-06 | 2025-11-04 | SGMT | Rozek Elizabeth | Chief Legal, Admin. Off | A - Grant | $0.00 | +9,855 | 193.6K | +5% | $0 |
| 2025-07-23 | 2025-07-21 | SGMT | Martins Eduardo Bruno | Chief Medical Off | S - Sale | $9.13 | -8,277 | 106.9K | -7% | -$75.6K | |
| 2025-07-23 | 2025-07-21 | SGMT | Happel David | Pres, CEO, Dir | S - Sale | $9.13 | -65.5K | 689.7K | -9% | -$597.8K | |
| 2025-07-23 | 2025-07-21 | SGMT | Rozek Elizabeth | GC, CCO | S - Sale | $9.13 | -10.8K | 183.7K | -6% | -$98.4K | |
| D | 2025-02-07 | 2025-02-06 | SGMT | Martins Eduardo Bruno | Chief Medical Off | A - Grant | $0.00 | +34.0K | 115.2K | +42% | $0 |
| D | 2025-02-07 | 2025-02-06 | SGMT | Rozek Elizabeth | GC, CCO | A - Grant | $0.00 | +34.0K | 194.5K | +21% | $0 |
| D | 2025-02-07 | 2025-02-06 | SGMT | Chauche Thierry | CFO | A - Grant | $0.00 | +17.0K | 17.0K | New | $0 |
| D | 2025-02-07 | 2025-02-06 | SGMT | Happel David | Pres, CEO, Dir | A - Grant | $0.00 | +116.0K | 755.2K | +18% | $0 |
| 2024-07-25 | 2024-07-23 | SGMT | Kemble George | Executive COB, Dir | S - Sale | $3.17 | -23.6K | 118.7K | -17% | -$74.9K | |
| 2024-07-23 | 2024-07-19 | SGMT | Kemble George | Executive COB, Dir | S - Sale | $3.10 | -14.1K | 142.3K | -9% | -$43.6K | |
| 2024-07-23 | 2024-07-19 | SGMT | Rozek Elizabeth | GC, CCO | S - Sale | $3.10 | -10.9K | 160.5K | -6% | -$33.8K | |
| 2024-07-23 | 2024-07-19 | SGMT | Martins Eduardo Bruno | Chief Medical Off | S - Sale | $3.10 | -8,357 | 81.2K | -9% | -$25.9K | |
| 2024-03-28 | 2024-03-26 | SGMT | Happel David | Pres, CEO, Dir | P - Purchase | $5.27 | +12.1K | 639.2K | +2% | +$63.8K | |
| 2024-01-31 | 2024-01-29 | SGMT | NEW ENTERPRISE ASSOCIATES 13 LP | 10% | J - Other | $0.00 | -850.0K | 3.00M | -22% | $0 | |
| 2024-01-31 | 2024-01-29 | SGMT | KERINS PATRICK J | 10% | J - Other | $0.00 | +13.1K | 13.1K | New | $0 | |
| MI | 2024-01-31 | 2024-01-29 | SGMT | KERINS PATRICK J | 10% | J - Other | $0.00 | -850.0K | 0 | -100% | $0 |
| I | 2024-01-31 | 2024-01-29 | SGMT | NEA 13 GP, Ltd | 10% | J - Other | $0.00 | -850.0K | 3.00M | -22% | $0 |
| M | 2024-01-31 | 2024-01-29 | SGMT | NEA 13 GP, Ltd | 10% | J - Other | $0.00 | 0 | 0 | New | $0 |
| MI | 2024-01-31 | 2024-01-29 | SGMT | SANDELL SCOTT D | 10% | J - Other | $0.00 | -843.0K | 0 | -100% | $0 |
| MI | 2024-01-31 | 2024-01-29 | SGMT | BASKETT FOREST | 10% | J - Other | $0.00 | -838.7K | 3.00M | -22% | $0 |
| 2023-12-08 | 2023-12-07 | SGMT | Happel David | Pres, CEO, Dir | P - Purchase | $4.10 | +1,600 | 627.1K | +0.3% | +$6,560 | |
| 2023-11-21 | 2023-11-17 | SGMT | Rozek Elizabeth | GC, CCO | A - Grant | $0.00 | +171.4K | 171.4K | New | $0 | |
| 2023-11-21 | 2023-11-17 | SGMT | Happel David | Pres, CEO, Dir | A - Grant | $0.00 | +624.9K | 625.5K | +105,917% | $0 | |
| 2023-11-21 | 2023-11-17 | SGMT | Martins Eduardo Bruno | Chief Medical Off | A - Grant | $0.00 | +89.6K | 89.6K | New | $0 | |
| 2023-11-21 | 2023-11-17 | SGMT | Kemble George | Executive COB, Dir | A - Grant | $0.00 | +150.8K | 156.4K | +2,678% | $0 | |
| 2023-11-20 | 2023-11-16 | SGMT | Happel David | Pres, CEO, Dir | P - Purchase | $2.35 | +590 | 590 | New | +$1,386 | |
| D | 2023-09-08 | 2023-09-07 | SGMT | Kemble George | Executive COB, Dir | M - OptEx | $0.79 | +5,630 | 5,630 | New | +$4,448 |
| DI | 2023-07-20 | 2023-07-18 | SGMT | KPCB PANDEMIC & BIO DEFENSE FUND LLC | 10% | C - Cnv Deriv | — | +1.86M | 1.90M | +4,800% | — |
| DMI | 2023-07-20 | 2023-07-18 | SGMT | KPCB PANDEMIC & BIO DEFENSE FUND LLC | 10% | J - Other | — | 0 | 0 | New | — |
| D | 2023-07-20 | 2023-07-18 | SGMT | KERINS PATRICK J | 10% | P - Purchase | $16.00 | +30.0K | 3.85M | +0.8% | +$480.0K |
| D | 2023-07-20 | 2023-07-18 | SGMT | KERINS PATRICK J | 10% | S - Sale+OE | $16.00 | -662 | 3.82M | -0.0% | -$10.6K |
| D | 2023-07-20 | 2023-07-18 | SGMT | KERINS PATRICK J | 10% | X - OptEx | $0.79 | +13.4K | 3.82M | +0.4% | +$10.6K |
| D | 2023-07-20 | 2023-07-18 | SGMT | KERINS PATRICK J | 10% | C - Cnv Deriv | — | +3.77M | 3.81M | +10,006% | — |
| DM | 2023-07-20 | 2023-07-18 | SGMT | KERINS PATRICK J | 10% | J - Other | — | 0 | 0 | New | — |
| D | 2023-07-20 | 2023-07-18 | SGMT | SEIDENBERG BETH C | Dir | C - Cnv Deriv | — | +84.8K | 84.8K | New | — |
| DI | 2023-07-20 | 2023-07-18 | SGMT | SEIDENBERG BETH C | Dir | C - Cnv Deriv | — | +1.86M | 1.90M | +4,800% | — |
| DI | 2023-07-20 | 2023-07-18 | SGMT | SEIDENBERG BETH C | Dir | A - Grant | — | +38.8K | 38.8K | New | — |
| DI | 2023-07-20 | 2023-07-18 | SGMT | SEIDENBERG BETH C | Dir | D - Sale to Iss | — | -38.8K | 0 | -100% | — |
| DI | 2023-07-20 | 2023-07-18 | SGMT | SEIDENBERG BETH C | Dir | P - Purchase | $16.00 | +46.9K | 46.9K | New | +$750.0K |
| D | 2023-07-20 | 2023-07-18 | SGMT | Parsey Merdad | Dir | C - Cnv Deriv | — | +4,117 | 12.8K | +47% | — |
| D | 2023-07-20 | 2023-07-18 | SGMT | Parsey Merdad | Dir | A - Grant | — | +8,677 | 8,677 | New | — |
| D | 2023-07-20 | 2023-07-18 | SGMT | Parsey Merdad | Dir | D - Sale to Iss | — | -8,677 | 0 | -100% | — |
| DI | 2023-07-20 | 2023-07-18 | SGMT | Wu Jinzi Jason | Dir | C - Cnv Deriv | — | +1.65M | 1.65M | New | — |
Purchase Sale Sale after option exercise All abbreviations